Agreement, Reliability, and Concurrent Validity of an Outdoor, Wearable-Based Walk Ratio Assessment in Healthy Adults and Chronic Stroke Survivors
Open Access
- 20 June 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 13, 857963
- https://doi.org/10.3389/fphys.2022.857963
Abstract
Purpose: The walk ratio (WR)—the step-length/cadence relation—is a promising measure for gait control. GPS-running watches deliver clinically relevant outcomes including the WR. The aim of this study was to determine test-retest agreement, reliability and concurrent validity of an outdoor WR assessment using a GPS-running watch. Methods: Healthy adults and moderate—high functioning stroke survivors (≥6 months), performed the 1 km-outdoor walk twice using a GPS-running watch (Garmin Forerunner 35, GFR35) and a Step Activity Monitor (SAM 3). Global cognition was assessed using the Montreal Cognitive Assessment. Test-retest agreement and reliability were assessed using Bland-Altman plots, standard error of measurement (SEM), intraclass correlation coefficients (ICCs) and smallest detectable changes (SDCs). Concurrent validity was determined by the mean difference (MD), standard error (SE), mean absolute percentage errors (MAPEs) and Spearman’s Rho between GFR35 and SAM3. WR values of the two groups were compared by a Welch’s test. A hierarchical multiple regression was performed with the WR as dependent variable and possible predictors as independent variables. Results: Fifty-one healthy adults [median: 60.0 (47.0, 67.0) years) and 20 stroke survivors [mean: 63.1 (12.4) years, median: 76 (30, 146) months post-stroke] were included. Test-retest agreement and reliability were excellent (SEM% ≤ 2.2, ICCs > 0.9, SDC% ≤ 6.1) and concurrent validity was high (MAPE < 5, ρ > 0.7) for those walking ≥ 1 m/s. Walking < 1 m/s impaired accurate step counting and reduced agreement, reliability, and validity. The WR differed between healthy adults and stroke survivors (t = −2.126, p = 0.045). The hierarchical regression model including stroke and global cognition (Montreal Cognitive Assessment, 0—30) explained 25% of the WR variance (ΔR2 = 0.246, p < 0.001). Stroke had no effect (β = −0.05, p = 0.682), but global cognition was a predictor for an altered WR (β = 0.44, p = 0.001). Discussion: The outdoor WR assessment using the GFR35 showed excellent test-retest agreement, reliability and concurrent validity in healthy adults and chronic stroke survivors walking at least 1 m/s. As the WR seems relevant in chronic stroke, future studies should further investigate this parameter.Keywords
This publication has 77 references indexed in Scilit:
- Gait Analysis Using Wearable SensorsSensors, 2012
- Walk ratio (step length/cadence) as a summary index of neuromotor control of gaitInternational Journal of Rehabilitation Research, 2011
- Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposedInternational Journal of Nursing Studies, 2011
- Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposedJournal of Clinical Epidemiology, 2011
- Wearable Systems for Monitoring Mobility-Related Activities in Chronic Disease: A Systematic ReviewSensors, 2010
- Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical TrialsStroke, 2007
- When to use agreement versus reliability measuresJournal of Clinical Epidemiology, 2006
- Quantifying Test-Retest Reliability Using the Intraclass Correlation Coefficient and the SEMJournal of Strength & Conditioning Research, 2005
- The influence of pain and pain-related fear and disability beliefs on walking velocity in chronic low back painInternational Journal of Rehabilitation Research, 2003
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986